Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)

NCT01164579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tasocitinib plus Methotrexate
DRUG: Tofacitinib plus placebo methotrexate
DRUG: Placebo tofacitinib plus Methotrexate

Sponsor

Pfizer